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Background
Acute Salmonella spp infections represent an important
public health issue worldwide, particularly among chil-
dren. Romania is a country with endemic Salmonella
infections which reports occasionally summer outbreaks.
Our study aimed to analyze the submitted cases and to
appreciate the germ’s susceptibility to antibiotics, starting
from the urging issue related to the emerging resistance
of Enterobacteriaceae to common drugs.
Methods
We conducted a clinic-based retrospective (2010-2013)
surveillance that analyzed the confirmed pediatric cases of
Salmonella spp infections treated at the National Institute
for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest,
Romania. The clinical and demographic patient features
followed were: age, sex, home environment, severity of the
disease and the complications. All the bacterial strains
were isolated after culturing the stool samples on differen-
tial culture media and the identification was performed
respecting the standard laboratory methodology. The anti-
biotic sensitivity spectrum was determined using the
API ATB G-5 tests for the following drugs: ampicillin,
amoxicillin/clavulanate, ampicillin/sulbactam, trimetho-
prim/sulfamethoxazole, nalidixic acid, fluoroquinolones,
tetracycline and third generation cephalosporins.
Results
During the studied period we identified 135 cases of acute
Salmonella spp infection among hospitalized children,
which stands for 8.5% of the total cases of acute diarrheal
diseases. The most affected age group was the 1-4 years
group, with a male predominance. The serotype distri-
bution was: AO – 12.6%, BO – 31.1%, CO – 19.2% and
DO – 37.1%. The chemosensitivity analysis revealed: 100%
sensitivity to fluoroquinolones, carbapenems and third gen-
eration cephalosporins, 92.6% sensitivity to nalidixic acid
and trimethoprim/sulfamethoxazole, 72.6% sensitivity to
amoxicillin/clavulanate, ampicillin/sulbactam, 62.9%
sensitivity to tetracycline and only 53.3% sensitivity to
ampicillin.
Conclusions
Salmonella spp induced enterocolitis represents a major
morbidity cause among children, especially during sum-
mers. The chemosensitivity analysis revealed excellent sen-
sitivity of the strains to fluoroquinolones, carbapenems,
third generation cephalosporins and nalidixic acid, good
sensitivity of the strains to trimethoprim/sulfamethoxa-
zole, amoxicillin/clavulanate and ampicillin/sulbactam and
weak sensitivity to tetracycline and ampicillin. The sub-
groups analysis showed the increasing number of resistant
strains in consecutive years, fact that highlights the impor-
tance of correct antibiotic prescription.
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